Latest filing published 21 Dec 2019 for Hansa Biopharma AB, €7,475.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Max Sakajja: trading record in brief
Max Sakajja appears in our data through filings on Hansa Biopharma AB shares, published by Finansinspektionen. Over a trading history stretching from 4 June 2019 to 20 December 2019, the count stands at 4 filings.
No open-market sale appears; the market trades are 4 purchases worth €66k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €14k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 21 December 2019, the filings show an open-market purchase worth €7,475 in Hansa Biopharma AB. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Max Sakajja
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ SEK 78.3011.4% of flowAktieISIN SE0002148817FI:csv-2477c7997fc69145d968Canonical exit: 18 Mar 2020 (T+90)
- 1,000 shares@ SEK 76.2611.1% of flowAktieISIN SE0002148817FI:csv-229aade488abc5848bccCanonical exit: 19 Mar 2020 (T+90)
- 5,000 shares@ SEK 45.5432.6% of flowTeckningsoptionISIN SE0002148817FI:csv-c00fcbf7bcc418daf793Canonical exit: 15 Sept 2019 (T+90)
- 1,900 shares@ SEK 164.8044.9% of flowAktieISIN SE0002148817FI:csv-f41cdeb805a48ed799baCanonical exit: 2 Sept 2019 (T+90)
4 of 4 declarations